Direkt zum Inhalt
Merck
  • Prospective investigation of nasal mupirocin, hexachlorophene body wash, and systemic antibiotics for prevention of recurrent community-associated methicillin-resistant Staphylococcus aureus infections.

Prospective investigation of nasal mupirocin, hexachlorophene body wash, and systemic antibiotics for prevention of recurrent community-associated methicillin-resistant Staphylococcus aureus infections.

Antimicrobial agents and chemotherapy (2011-11-16)
Loren G Miller, Jennifer Tan, Samantha J Eells, Esther Benitez, Allen B Radner
ZUSAMMENFASSUNG

Recurrent community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) skin infections are an increasingly common problem. However, there are no data on the efficacy of decolonization regimens. We prospectively evaluated 31 patients with recurrent CA-MRSA skin infections who received nasal mupirocin, topical hexachlorophene body wash, and an oral anti-MRSA antibiotic. The mean number of MRSA infections after the intervention decreased significantly from baseline (0.03 versus 0.84 infections/month, P = <0.0001). This regimen appears promising at preventing recurrent CA-MRSA infections.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Supelco
2,2′-Methylen-bis-(3,4,6-trichlorphenol), PESTANAL®, analytical standard